This is a plain-English translation of the academic paper above, prepared for patients, referring clinicians, and other non-specialist readers. It preserves the structure of the original paper while removing technical jargon. For the full clinical paper, follow the PubMed or DOI links.
Background
Whether women and men respond differently to an injection of micro-fragmented adipose tissue (MFAT — a small sample of the patient’s own fat) for painful knee osteoarthritis, followed up over two years.
Rationale
For decades, women have been under-represented in orthopaedic trials, and many published studies do not separate the results by sex. That can hide real differences in how a treatment works. We deliberately set out to analyse the men and women in our group separately, using open-source statistical software so that anyone can reproduce the analysis.
Results
Women showed a greater improvement in pain and function after MFAT than men, and that difference was both statistically significant and clinically meaningful. Both sexes improved — this is not a treatment that works only for women — but the size of the effect was larger in women. The reasons are likely a combination of genetic, hormonal, environmental, and age-related factors.
Implications
The result is encouraging for women considering MFAT for knee arthritis, but it is also an example of why studies should always look at men and women separately. We do not yet know exactly why the response differs — that needs more research — but acknowledging the difference is the first step to refining the treatment for everyone.
Source: Borg TM, Heidari N, Noorani A, Slevin M, Cullen A, Olgiati S, et al.. Gender-Specific Response in Pain and Function to Biologic Treatment of Knee Osteoarthritis: A Gender-Bias-Mitigated, Observational, Intention-to-Treat Study at Two Years. Stem Cells International 2021;2021:6648437. doi:10.1155/2021/6648437
Read full open-access paper (PDF) → Read original on PubMed → ← Back to research library